Indeed, combined low miR-223 with high target mRNA ECT2 expression in osteosarcoma was significantly associated with tumour grade, chemo-resistance, development of metastases and tumour recurrence [57], as was in that same cohort, the combined low miR-183 with high target mRNA EZRIN expression. This evidence concerns the gene ECT2 and neoplasm.